Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3MX5

Lassa fever virus nucleoprotein complexed with UTP

Summary for 3MX5
Entry DOI10.2210/pdb3mx5/pdb
Related3MWP 3MWT 3MX2
DescriptorNucleoprotein, URIDINE 5'-TRIPHOSPHATE, ZINC ION, ... (4 entities in total)
Functional Keywordsnucleoprotein, lassa fever virus, structural genomics, scottish structural proteomics facility, sspf, nuclear protein
Biological sourceLassa virus (LASV)
Cellular locationVirion: P13699
Total number of polymer chains3
Total formula weight193544.09
Authors
Qi, X.,Lan, S.,Wang, W.,Schelde, L.M.,Dong, H.,Wallat, G.,Liang, Y.,Ly, H.,Dong, C.,Scottish Structural Proteomics Facility (SSPF) (deposition date: 2010-05-06, release date: 2010-12-01, Last modification date: 2023-09-06)
Primary citationQi, X.,Lan, S.,Wang, W.,Schelde, L.M.,Dong, H.,Wallat, G.D.,Ly, H.,Liang, Y.,Dong, C.
Cap binding and immune evasion revealed by Lassa nucleoprotein structure.
Nature, 468:779-783, 2010
Cited by
PubMed Abstract: Lassa virus, the causative agent of Lassa fever, causes thousands of deaths annually and is a biological threat agent, for which there is no vaccine and limited therapy. The nucleoprotein (NP) of Lassa virus has essential roles in viral RNA synthesis and immune suppression, the molecular mechanisms of which are poorly understood. Here we report the crystal structure of Lassa virus NP at 1.80 Å resolution, which reveals amino (N)- and carboxy (C)-terminal domains with structures unlike any of the reported viral NPs. The N domain folds into a novel structure with a deep cavity for binding the m7GpppN cap structure that is required for viral RNA transcription, whereas the C domain contains 3'-5' exoribonuclease activity involved in suppressing interferon induction. To our knowledge this is the first X-ray crystal structure solved for an arenaviral NP, which reveals its unexpected functions and indicates unique mechanisms in cap binding and immune evasion. These findings provide great potential for vaccine and drug development.
PubMed: 21085117
DOI: 10.1038/nature09605
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.903 Å)
Structure validation

227111

건을2024-11-06부터공개중

PDB statisticsPDBj update infoContact PDBjnumon